EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Type 2 Diabetes Pharmacotherapy De-Escalation Through AI-Enabled Lifestyle Modifications: A Randomized Clinical Trial

Kevin M. Pantalone, Huijun Xiao, James Bena, Shannon Morrison, Shannon Downie, Ana Maria Boyd, Lisa Shah, Bree Willis, Jewel Beharry-Diaz, Alex Milinovich, Shashank Joshi, Francine R. Kaufman und 1 weitere

NEJM Catalyst · 20.08.2025 · 6 (9)

DOI: 10.1056/cat.25.0016 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift NEJM Catalyst, erschienen am 20.08.2025. Verfasst von Kevin M. Pantalone und 12 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Pantalone, K. M., Xiao, H., Bena, J., Morrison, S., Downie, S., Boyd, A. M., Shah, L., Willis, B., Beharry-Diaz, J., Milinovich, A., Joshi, S., Kaufman, F. R., & Mechanick, J. I. (2025). Type 2 Diabetes Pharmacotherapy De-Escalation Through AI-Enabled Lifestyle Modifications: A Randomized Clinical Trial. NEJM Catalyst, 6(9). https://doi.org/10.1056/cat.25.0016

Vancouver

Pantalone KM, Xiao H, Bena J, Morrison S, Downie S, Boyd AM, et al. Type 2 Diabetes Pharmacotherapy De-Escalation Through AI-Enabled Lifestyle Modifications: A Randomized Clinical Trial. NEJM Catalyst. 2025;6(9). doi:10.1056/cat.25.0016

BibTeX
@article{Pantalone2025,
  author = {Pantalone, Kevin M. and Xiao, Huijun and Bena, James and Morrison, Shannon and Downie, Shannon and Boyd, Ana Maria and Shah, Lisa and Willis, Bree and Beharry-Diaz, Jewel and Milinovich, Alex and Joshi, Shashank and Kaufman, Francine R. and Mechanick, Jeffrey I.},
  title = {Type 2 Diabetes Pharmacotherapy De-Escalation Through AI-Enabled Lifestyle Modifications: A Randomized Clinical Trial},
  journal = {NEJM Catalyst},
  year = {2025},
  volume = {6},
  number = {9},
  doi = {10.1056/cat.25.0016}
}
Kostenlos starten →